AbCellera Biologics Inc.
ABCL
$3.16
$0.0050.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.29% | -17.75% | -18.16% | -15.75% | -12.36% |
| Total Receivables | 84.10% | 43.10% | 68.87% | 48.22% | -30.93% |
| Inventory | -- | -- | -- | -- | -49.00% |
| Prepaid Expenses | -62.18% | -60.82% | -64.04% | -62.01% | 18.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -60.34% | -61.86% | 0.00% |
| Total Current Assets | -6.02% | -13.83% | -19.21% | -17.10% | -13.47% |
|
|
|||||
| Total Current Assets | -6.02% | -13.83% | -19.21% | -17.10% | -13.47% |
| Net Property, Plant & Equipment | 13.40% | 18.33% | 19.50% | 22.82% | 31.26% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -65.31% | -65.03% | -57.63% | -32.42% | -7.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -41.33% | 2.43% | 177.34% | -1.15% | 74.47% |
| Total Assets | -8.13% | -8.57% | -7.89% | -8.11% | -2.32% |
|
|
|||||
| Total Accounts Payable | 21.92% | 20.09% | 99.60% | 26.44% | 53.15% |
| Total Accrued Expenses | 11.94% | 8.67% | -36.56% | -37.34% | -41.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -16.16% | -24.96% | -8.02% | -5.88% | -5.74% |
| Total Finance Division Other Current Liabilities | -50.04% | -61.77% | -56.73% | -60.18% | 13.60% |
| Total Other Current Liabilities | -50.04% | -61.77% | -56.73% | -60.18% | 13.60% |
| Total Current Liabilities | -28.11% | -35.63% | -27.82% | -40.81% | 17.07% |
|
|
|||||
| Total Current Liabilities | -28.11% | -35.63% | -27.82% | -40.81% | 17.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.15% | -14.71% | -11.85% | -14.89% | -11.89% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.98% | 14.82% | 17.29% | 13.30% | 30.73% |
| Total Liabilities | -3.59% | -9.32% | -4.46% | -11.93% | 15.12% |
|
|
|||||
| Common Stock & APIC | 7.41% | 7.92% | 8.27% | 8.28% | 8.26% |
| Retained Earnings | -70.19% | -58.21% | -53.77% | -43.12% | -38.05% |
| Treasury Stock & Other | -285.35% | -154.53% | 15.62% | -9.16% | 10.14% |
| Total Common Equity | -9.46% | -8.35% | -8.85% | -7.02% | -6.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.46% | -8.35% | -8.85% | -7.02% | -6.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.46% | -8.35% | -8.85% | -7.02% | -6.50% |
|
|
|||||